Keyphrases
Preterm Infants
100%
Monocytes
100%
Hyperinflammation
100%
Lipopolysaccharide-induced
100%
Pentoxifylline
100%
Preterm Neonates
33%
CD14
33%
MRNA Level
22%
Interleukin-10
22%
Lipopolysaccharide
22%
Messenger RNA (mRNA)
22%
Phagocytosis
22%
CD11
22%
TLR4 Expression
22%
Interleukin-1β
11%
Tumor Necrosis Factor-α
11%
Toll-like Receptor 4 (TLR4)
11%
Quantitative PCR
11%
Term Infants
11%
Dose Effect
11%
Blood Samples
11%
Interleukin-6 Levels
11%
All Ages
11%
Age Groups
11%
Flow Cytometry
11%
Anti-inflammatory Effect
11%
CD11b
11%
Toll-like
11%
CD80
11%
Cytokine Secretion
11%
Age-related Differences
11%
Immunomodulating
11%
Adjunctive Therapy
11%
Cord Blood Sample
11%
Neonatal Sepsis
11%
Anti-inflammatory Properties
11%
Surface Markers
11%
Adult Blood
11%
TLR4 Signaling
11%
Derivates
11%
CD71
11%
Blood Control
11%
Cellular RNA
11%
Methylxanthines
11%
CD64
11%
Adult Control
11%
INIS
infants
100%
monocytes
100%
in vitro
100%
lipopolysaccharides
100%
interleukins
66%
levels
50%
adults
50%
control
33%
blood
33%
production
33%
inflammation
33%
messenger-rna
33%
neonates
33%
phagocytosis
33%
doses
16%
receptors
16%
comparative evaluations
16%
cytokines
16%
pcr
16%
secretion
16%
surfaces
16%
tumor necrosis factor
16%
age groups
16%
age dependence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
100%
Pentoxifylline
100%
Toll Like Receptor 4
44%
Prematurity
22%
Interleukin 10
22%
Messenger RNA
22%
Interleukin 6
11%
Tumor Necrosis Factor
11%
Cytokine
11%
Anti-Inflammatory Drug
11%
Flow Cytometry
11%
Antiinflammatory Activity
11%
Interleukin 1beta
11%
RNA Directed DNA Polymerase
11%
Methylxanthine
11%
Newborn Sepsis
11%
Immunology and Microbiology
Pentoxifylline
100%
TLR4
44%
CD14
33%
Interleukin 10
22%
Phagocytosis
22%
CD11
22%
Interleukin 6
11%
Tumor Necrosis Factor Alpha
11%
Interleukin 1beta
11%
Antiinflammatory Activity
11%
CD80
11%
Cytokine Release
11%
Reverse Transcription Polymerase Chain Reaction
11%